{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:02:11Z","timestamp":1784761331985,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.transproceed.2010.12.055","type":"journal-article","created":{"date-parts":[[2011,6,25]],"date-time":"2011-06-25T09:55:48Z","timestamp":1308995748000},"page":"1839-1846","source":"Crossref","is-referenced-by-count":15,"title":["Everolimus Plus Dosage Reduction of Cyclosporine in Cardiac Transplant Recipients with Chronic Kidney Disease: A Two-Year Follow-up Study"],"prefix":"10.1016","volume":"43","author":[{"given":"U.","family":"Fuchs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Zittermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Hakim-Meibodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"B\u00f6rgermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.F.","family":"Gummert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2010.12.055_bib1","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.healun.2005.05.018","article-title":"twenty-second official adult heart transplant report-2005","volume":"24","author":"Taylor","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2010.12.055_bib2","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1600-6143.2006.01248.x","article-title":"Kidney disease after heart and lung transplantation","volume":"6","author":"Bloom","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2010.12.055_bib3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1034\/j.1399-0012.2002.01119.x","article-title":"Calcineurin inhibitor nephrotoxicity: reduction in dose results in marked improvement in renal function in patients with coexisting chronic allograft nephropathy","volume":"16","author":"Pilmore","year":"2002","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2010.12.055_bib4","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.healun.2008.04.001","article-title":"No association between single nucleotide polymorphisms and the development of nephrotoxicity after orthotopic heart transplantation","volume":"27","author":"Klauke","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2010.12.055_bib5","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.healun.2008.07.020","article-title":"Avoidance of calcineurin inhibitors with use of proliferation signal inhibitors in de novo heart transplantation with renal failure","volume":"27","author":"Gonz\u00e1lez-V\u0131\u0301lchez","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2010.12.055_bib6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00007890-199707150-00008","article-title":"SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo","volume":"64","author":"Sculer","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2010.12.055_bib7","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0952-7915(98)80172-6","article-title":"Mammalian target of rapamycin: immunosuppressive drugs uncover a novel pathway of cytokine receptor signaling","volume":"10","author":"Abraham","year":"1998","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.transproceed.2010.12.055_bib8","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.rmed.2003.12.016","article-title":"Role of sirolimus, a novel immunosuppressive drug in heart and lung transplantation","volume":"98","author":"Shitrit","year":"2004","journal-title":"Respir Med"},{"key":"10.1016\/j.transproceed.2010.12.055_bib9","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1517\/13543784.11.12.1845","article-title":"Review of the proliferation inhibitor everolimus","volume":"11","author":"Nashan","year":"2002","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.transproceed.2010.12.055_bib10","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00075198-200112000-00003","article-title":"Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies","volume":"7","author":"Olyaei","year":"2001","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.transproceed.2010.12.055_bib11","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1016\/j.transproceed.2005.10.005","article-title":"Everolimus (certican) in heart transplantation: optimizing renal function through minimizing cyclosporine exposure","volume":"37","author":"Lehmkuhl","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2010.12.055_bib12","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/S0041-1345(02)03098-1","article-title":"Sirolimus and tacrolimus in clinical cardiac transplantation","volume":"34","author":"Pham","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2010.12.055_bib13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1055\/s-2004-820880","article-title":"First experience with rapamycin-based immunosuppression to improve kidney function after heart transplantation","volume":"52","author":"Tr\u00f6sch","year":"2004","journal-title":"Thorac Cardiovasc Surg"},{"key":"10.1016\/j.transproceed.2010.12.055_bib14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1432-2277.2005.00258.x","article-title":"Sirolimus in de novo heart transplant recipients with severe renal impairment","volume":"19","author":"Vazquez de Prada","year":"2006","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2010.12.055_bib15","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/01.tp.0000177644.45192.a3","article-title":"Switch from calcineurin inhibitors to sirolimus-induced renal recovery in heart transplant recipients in the midterm follow-up","volume":"81","author":"Bestetti","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2010.12.055_bib16","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/01.tp.0000276959.56959.69","article-title":"Replacement of calcineurin-inhibitors with sirolimus as primary immunosuooression in stable cardiac transplant recipients","volume":"84","author":"Raichlin","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2010.12.055_bib17","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJMoa022171","article-title":"Everolimus for the prevention of allograft rejection and vasculopathy in cardiac transplant recipients","volume":"349","author":"Eisen","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2010.12.055_bib18","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.healun.2007.03.005","article-title":"Prevention of acute rejection and allograft vasculopathy by everolimus in cardiac transplants recipients: a 24-month analysis","volume":"26","author":"Vigan\u00f3","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2010.12.055_bib19","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.healun.2007.02.008","article-title":"Observational study with everolimus (Certican) in combination with low-dose cyclosporine in de novo heart transplant recipients","volume":"26","author":"Lehmkuhl","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2010.12.055_bib20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.trim.2006.02.001","article-title":"Everolimus and reduced cyclosporine trough levels in maintenance heart transplant recipients","volume":"16","author":"Schweiger","year":"2006","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.transproceed.2010.12.055_bib21","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1161\/01.CIR.0000150332.42276.69","article-title":"Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs","volume":"110","author":"Lindenfeld","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.transproceed.2010.12.055_bib22","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1399-0012.2007.00686.x","article-title":"Comparison of sirolimus and everolimus in their effects on blood lipid profiles and haematological parameters in heart transplant recipients","volume":"21","author":"Tenderich","year":"2007","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2010.12.055_bib23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1432-2277.2009.00940.x","article-title":"Reduction of cyclosporine following the introduction of everolimus in maintenance heart transplant recipients: a pilot study","volume":"23","author":"Ross","year":"2010","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2010.12.055_bib24","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.transproceed.2010.12.055_bib25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00007890-198707000-00027","article-title":"Cyclosporin-induced acute renal dysfunction in the rat","volume":"44","author":"English","year":"1987","journal-title":"Transplantation"},{"issue":"suppl 2","key":"10.1016\/j.transproceed.2010.12.055_bib26","doi-asserted-by":"crossref","first-page":"229S","DOI":"10.1016\/j.transproceed.2004.01.021","article-title":"Cyclosporine nephrotoxicity","volume":"36","author":"Busauschina","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2010.12.055_bib27","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/j.jacc.2008.03.025","article-title":"Managing dyslipoproteinemia in chronic kidney disease","volume":"51","author":"Harper","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.transproceed.2010.12.055_bib28","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0735-1097(01)01337-7","article-title":"Impact of lipid abnormalities in development and progression of transplant coronary disease: a serial intravascular ultrasound study","volume":"38","author":"Kapadia","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.transproceed.2010.12.055_bib29","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.hco.0000203184.89158.16","article-title":"Cardiac allograft vasculopathy: pathology, prevention and treatment","volume":"21","author":"Kass","year":"2006","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.transproceed.2010.12.055_bib30","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/00007890-200504270-00020","article-title":"Immunosuppressive therapy with everolimus can be associated with potentially life-theratening lingual angioedema","volume":"79","author":"Fuchs","year":"2005","journal-title":"Transplantation"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134511002508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134511002508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T19:23:01Z","timestamp":1543692181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134511002508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0041134511002508"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2010.12.055","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}